TAP Path prunes Virchow2, a major pathology foundation model, posting 87.98% accuracy on a 32 class benchmark; the result is a research compute claim, not a hospital one.
A new compression method called TAP-Path reportedly trims one of the largest pathology foundation models, AI systems trained on microscope-slide images of human tissue, by about a quarter of its parameters and over a third of its compute, while posting a small accuracy gain on the paper's own benchmark.
The method restructures a pretrained Virchow2 encoder rather than distilling it into a separate student model, according to the paper's abstract. It keeps 24 of 32 transformer blocks, retains 70% of patch tokens, and adds a lightweight gated task head for final classification. The authors report a 24.96% parameter cut (631.24M to 473.70M) and a 35.20% analytical compute cut (340.13G to 220.40G FLOPs).
On a 32-class internal histopathology benchmark, across three task-head optimization seeds, TAP-Path reached 87.98 ± 0.067% test accuracy, 81.26 ± 0.49% balanced accuracy, and 82.38 ± 0.48% macro-F1. The paper reports full Virchow2 at 86.89% and UNI2-h at 87.67% on the same benchmark, as point numbers rather than a matched-budget study. A frozen external evaluation on 433 samples from the CPTAC cancer genomics repository produced 91.22 ± 0.83% accuracy.
The authors also report reliability signals: a Brier score of 0.1800 ± 0.0005 and a failure-detection AUROC of 0.9047 ± 0.0060, both derived from the paper's own evaluation protocol.
The paper does not report deployment, clinical use, or vendor involvement, and the gains come from the authors' own benchmark. Whether that trade-off survives a hospital-grade evaluation is the next test the paper does not run.